Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: D-dimer is used widely as a diagnostic aid in low- and moderate-risk patients with suspected venous thromboembolism (VTE). While our laboratory utilizes VIDAS D-dimer analyzer (bioMérieux SA, France), our emergency department (ED) recently procured a D-dimer analyzer AQT90 FLEX (Radiometer Medical ApS, Denmark) for point of care testing (POCT) to facilitate patient management. We aimed to determine whether the time taken to receive D-dimer results using the 2 different analyzers differed significantly and to quantify the limits of agreement between the results of the 2 methods measured on the same patient. Methods: Adult patients presenting to the ED and requiring diagnostic workup for suspected VTE were included in this prospective observational study. Patients underwent simultaneous D-dimer measurements using the 2 different analyzers. Results: The paired results from 104 patients were analyzed. The median time for the Ddimer results from triage by VIDAS was 258 min (Inter-quartile range [IQR], 173-360) and by POCT was 146 min (IQR, 55-280.5); the median time difference was 101.5 min (IQR, 82-125.5). On an average, POCT D-dimer values were 15% lower on the same sample (limits of agreement, 34-213%). POCT predicted 83% of VIDAS positive results (sensitivity, 83.3%[95% confidence interval (CI), 70.4-91.3%]; specificity, 100% [95% CI, 93.6-100%]). All patients with positive imaging were identified correctly by both methods. Conclusions: POCT delivers D-dimer results in significantly shorter turnaround times than pathology services; however, poor bioequivalence between VIDAS and POCT raises the issue of acceptability for use in the ED.
Abstract
Background: D-dimer is used widely as a diagnostic aid in low- and moderate-risk patients with suspected venous thromboembolism (VTE). While our laboratory utilizes VIDAS D-dimer analyzer (bioMérieux SA, France), our emergency department (ED) recently procured a D-dimer analyzer AQT90 FLEX (Radiometer Medical ApS, Denmark) for point of care testing (POCT) to facilitate patient management. We aimed to determine whether the time taken to receive D-dimer results using the 2 different analyzers differed significantly and to quantify the limits of agreement between the results of the 2 methods measured on the same patient. Methods: Adult patients presenting to the ED and requiring diagnostic workup for suspected VTE were included in this prospective observational study. Patients underwent simultaneous D-dimer measurements using the 2 different analyzers. Results: The paired results from 104 patients were analyzed. The median time for the Ddimer results from triage by VIDAS was 258 min (Inter-quartile range [IQR], 173-360) and by POCT was 146 min (IQR, 55-280.5); the median time difference was 101.5 min (IQR, 82-125.5). On an average, POCT D-dimer values were 15% lower on the same sample (limits of agreement, 34-213%). POCT predicted 83% of VIDAS positive results (sensitivity, 83.3%[95% confidence interval (CI), 70.4-91.3%]; specificity, 100% [95% CI, 93.6-100%]). All patients with positive imaging were identified correctly by both methods. Conclusions: POCT delivers D-dimer results in significantly shorter turnaround times than pathology services; however, poor bioequivalence between VIDAS and POCT raises the issue of acceptability for use in the ED.
참고문헌 (13)
- Lee-Lewandrowski E, "Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization", Am J Clin Pathol, 132, pp.326~331 (2009)
- Walker JB, "The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin", J Biol Chem, 274, pp.5201~5212 (1999)
- Greenberg CS, "Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads", Am J Clin Pathol, 87, pp.94~100 (1987)
- Dempfle CE, "Validation, calibration, and specificity of quantitative D-dimer assays", Semin Vasc Med, 5, pp.315~320 (2005)
- Pittet JL, "VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma", Clin Chem, 42, pp.410~415 (1996)
- Scarano L, "Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis", Thromb Res, 86, pp.93~99 (1997)
- Di Nisio M, "Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review", J Thromb Haemost, 5, pp.296~304 (2007)
- Perrier A, "Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study", Am J Med, 116, pp.291~299 (2004)
- Sidelmann JJ, "Analytical and clinical validation of a new point-of-care testing system for determination of D-Dimer in human blood", Thromb Res, 126, pp.524~530 (2010)
- Wells PS, "A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process", J Intern Med, 243, pp.15~23 (1998)
- Bland JM, "Statistical methods for assessing agreement between two methods of clinical measurement", Lancet, 1, pp.307~310 (1986)
- Brotman DJ, "Limitations of Ddimer testing in unselected inpatients with suspected venous thromboembolism", Am J Med, 114, pp.276~282 (2003)
- Geersing GJ, "Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis", BMJ, 339, pp.b2990~ (2009)